Shares of Immunomedics (IMMU) push 3.5% higher premarket after the firm nabs a broad-based...

|By:, SA News Editor

Shares of Immunomedics (IMMU) push 3.5% higher premarket after the firm nabs a broad-based patent from the USPTO related to antibody-based products for the treatment of cancer.